EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours

Jorge Choque, Aparicio Aguilar iD, Javier Enciso-Benavides iD, Nancy Rojas-Moran iD, Nathaly Enciso iD, Carlos Castañeda Altamirano iD, Miluska Castillo, Luis Alfaro iD, Javier Enciso iD

Analytical Cellular Pathology · 2026

DOI: 10.1155/ancp/3265988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von Jorge Choque und 8 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Group, Scientific University of the South, Lima, Peru. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Midkine, Neoplastic Stem Cells, Biomarkers, Tumor. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sistema Nacional de Ciencia, Tecnología e Innovación Tecnológica, Universidad Científica del Sur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is no specific therapy for triple‐negative breast cancer (TNBC), and the recurrence rate is high. Cancer stem cells (CSCs) play an important role in cancer chemoresistance and metastasis, but there is no consensus marker in this type of cancer. The aim of this study was to identify CSC biomarkers in the plasma secretome of TNBC patients.

Methods

CD44+/CD24− CSCs were isolated from MDA‐MB‐436 and MDA‐MB‐231 (ATCC) lines by magnetic immunoselection. The extracellular vesicles (EVs) of CSCs were isolated by size exclusion chromatography (SEC) of conditioned medium (CM) without fetal bovine serum (FBS) and blood plasma from TNBC and healthy women. Tetraspanins CD9 and CD81 identified the EVs, while electron microscopy determined the morphology and tunable resistive pulse sensing (TRPS) established particle size. Luminex technology was used to determine the presence of L1 cell adhesion molecule (L1CAM), carbonic anhydrase IX (CA9), mesothelin, midkine, hepsin, kallikrein‐6 (KLK6), transglutaminase 2 (TGM2), aldehyde dehydrogenase 1a1 (ALDH1A1), epithelial cell adhesion molecule (EpCAM), and differentiation cluster 44 (CD44).

Results

Particles of 0–200 nm in size were more frequent in CSC‐MDA‐MB‐436, while particles of 201–500 nm were more frequent in CSC‐MDA‐MB‐231. In blood plasma, the particle size was 150–250 nm in TNBC patients and 150–300 nm in healthy individuals. Particle concentrations were 1.3 × 10 10 in CSCs of the MDA‐MB‐231 (CSC‐MDA‐MB‐231) cell line and 3.8 × 10 7 in the MDA‐MB‐231 cell line (L‐MDA‐MB‐231). The concentration of CSCs in MDA‐MB‐436 was 2.7 × 10 8 compared to 9.4 × 10 7 in L‐MDA‐MB‐436. Midkine and CA9 were present in the EVs of both CSC lines and in the plasma of women with TNBC but absent in the blood plasma of healthy women. Midkine showed better statistical discrimination.

Conclusions

The size and concentration of EVs are heterogeneous. Midkine and CA9 are produced by CSCs in women with TNBC and may be possible biomarkers of these cells in this tumour type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMidkineNeoplastic Stem CellsBiomarkers, TumorCarbonic Anhydrase IXAntigens, NeoplasmHumansFemaleMDA-MB-231 CellsExtracellular VesiclesCell Line, TumorSecretome

Stichwörter der Autor:innen

CA9biomarkercancer stem cellsmidkinesecretometriple-negative breast cancer

Substanzen

MidkineBiomarkers, TumorCarbonic Anhydrase IXAntigens, NeoplasmCA9 protein, human

Autor:innen und Institutionen

  • Regenerative Medicine Group, Scientific University of the South, Lima, Peru.
  • Faculty of Biology, National University of San Marcos, Lima, Peru, unmsm.edu.pe.
  • Stem Cell Laboratory, Enciso Veterinary Clinic, Lima, Peru.
  • Electron Microscopy Laboratory, Faculty of Medicine, National University of San Marcos, Lima, Peru, unmsm.edu.pe.
  • National Institute of Neoplastic Diseases, Lima, Peru.

ORCID-Profile: Aparicio Aguilar, Javier Enciso-Benavides, Nancy Rojas-Moran, Nathaly Enciso, Carlos Castañeda Altamirano, Luis Alfaro, Javier Enciso

Förderung

  • Sistema Nacional de Ciencia, Tecnología e Innovación Tecnológica
  • Universidad Científica del Sur

Zitieren

APA

Choque, J., Aguilar, A., Enciso-Benavides, J., Rojas-Moran, N., Enciso, N., Altamirano, C. C., Castillo, M., Alfaro, L., & Enciso, J. (2026). Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/3265988

Vancouver

Choque J, Aguilar A, Enciso-Benavides J, Rojas-Moran N, Enciso N, Altamirano CC, et al. Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/3265988

BibTeX
@article{Choque2026,
  author = {Choque, Jorge and Aguilar, Aparicio and Enciso-Benavides, Javier and Rojas-Moran, Nancy and Enciso, Nathaly and Altamirano, Carlos Castañeda and Castillo, Miluska and Alfaro, Luis and Enciso, Javier},
  title = {Midkine and CA9 Are Potential Cancer Stem Cell Biomarkers in Triple‐Negative Breast Tumours},
  journal = {Analytical Cellular Pathology},
  year = {2026},
  doi = {10.1155/ancp/3265988}
}
Kostenlos starten →